Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats

Acta Pharmacologica Sinica
Lian LiJing Zhang

Abstract

To determine the cardioprotective action of ghrelin and des-octanoyl ghrelin in rats with isoproterenol-induced myocardial injury. Rats were subcutaneously injected with isoproterenol (ISO; 20, 10, and 5 mg/kg) on d 1, 2 and 3, respectively, and then 3 mg/kg for the next 7 d with or without ghrelin or des-octanoyl-ghrelin (100 microg/kg, twice daily). Plasma ghrelin and growth hormone levels were assayed using radioimmunoassay methods. Growth hormone secretagogue receptor (GHSR) and ghrelin mRNA were determined using RT-PCR. The maximal binding capacity and the affinity for [3H]ghrelin were determined by receptor binding assays. Compared with controls, ISO-treated rats showed severe myocardial injury, cardiomegaly, infarction-like necrosis and massive fibrosis with increases in irradiated-ghrelin (ir-ghrelin) content in plasma by 67% and myocardia by 66% and in the mRNA level in the myocardia by 93% (P<0.01). ISO-treated rats had 95% (P<0.01) higher GHSR mRNA levels in the myocardia. The maximal binding capacity of [3H]ghrelin for myocardial sarcolemma was higher in ISO-treated rats than in controls. Ghrelin administration improved cardiac function and ameliorated cardiomegaly and attenuated myocardial lipid peroxidation injury...Continue Reading

References

Jun 1, 1979·Analytical Biochemistry·H OhkawaK Yagi
Jan 1, 1989·Free Radical Biology & Medicine·F P CorongiuM A Dessi
Jun 1, 1994·The Journal of Clinical Investigation·M YoungJ Funder
Nov 1, 2000·Nature·M TschöpM L Heiman
Aug 7, 2002·British Journal of Pharmacology·Katherine E Wiley, Anthony P Davenport
Nov 2, 2002·Hypertension·Kiyoshi MatsumuraMitsuo Iida
Mar 26, 2003·Cytokine & Growth Factor Reviews·Penny L JefferyLisa K Chopin
May 7, 2003·Biochemical and Biophysical Research Communications·Masahiko KishimotoKazuo Chihara
Sep 13, 2003·European Journal of Pharmacology·Ivano BedendiGiampiero Muccioli
Oct 11, 2003·Biochemical and Biophysical Research Communications·Yoshito ShimizuMasao Yoshizumi
Jan 13, 2004·Journal of Cardiovascular Pharmacology·Lin ChangChaoshu Tang
May 8, 2004·Molecular and Cellular Endocrinology·Ryo ImanishiKatsusuke Yano

❮ Previous
Next ❯

Citations

Nov 4, 2010·European Journal of Applied Physiology·Ya-Wen HsuPaulus S Wang
Mar 8, 2008·Endocrine Journal·Simoni A KatergariNikos K Nikolettos
Jan 2, 2014·Scientifica·Christine Delporte
Jan 30, 2014·Future Oncology·David C Currow, Amy P Abernethy
Aug 28, 2010·International Journal of Peptides·Johannes D Veldhuis, Cyril Y Bowers
Jun 5, 2015·Molecular Metabolism·T D MüllerM H Tschöp
Aug 1, 2015·Pflügers Archiv : European journal of physiology·Bjorn T TamParco M Siu
Mar 28, 2013·International Journal of Peptides·M Khazaei, Z Tahergorabi
May 12, 2015·International Journal of Endocrinology·Elia AngelinoNicoletta Filigheddu
Sep 7, 2014·Acta Diabetologica·Xiao M PeiParco M Siu
May 27, 2011·Journal of Human Hypertension·O UkkolaY A Kesäniemi
Jan 16, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Montserrat MorenoRamón Bataller
Jun 24, 2010·Journal of Peptide Science : an Official Publication of the European Peptide Society·Jian-Ping XuChao-Shu Tang
Feb 7, 2019·Canadian Journal of Physiology and Pharmacology·Ebru Çetin
May 1, 2009·Expert Review of Endocrinology & Metabolism·Ichiro KishimotoKenji Kangawa
Sep 17, 2013·Clinical and Experimental Dermatology·S S KocaA Isik
Dec 12, 2013·American Journal of Physiology. Endocrinology and Metabolism·Xiao M PeiParco M Siu
Dec 30, 2009·Pharmacological Reviews·Chih-Yen ChenAkio Inui
Jun 8, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Giuseppe AlloattiGiampiero Muccioli
Nov 16, 2019·Journal of Basic and Clinical Physiology and Pharmacology·Mona G ElhadidyAhmed E Eladel
Oct 18, 2016·Cardiology in Review·Brian M Lilleness, William H Frishman
Mar 21, 2016·Journal of Biochemical and Molecular Toxicology·Govindan Sangaran JagadeeshPalanisamy Selvaraj
Feb 13, 2016·Journal of Neurochemistry·Jacqueline A BaylissZane B Andrews
Oct 31, 2017·Journal of Diabetes Research·Jéssica Aparecida da Silva PereiraPedro Manoel Mendes de Moraes-Vieira
Mar 29, 2014·British Journal of Pharmacology·Brid CallaghanJohn B Furness
May 13, 2020·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Nancy Safwat Younis
Oct 1, 2020·Scientific Reports·Anca D PetrescuSharon DeMorrow
Oct 8, 2020·Heart Failure Reviews·Shreyasi Gupta, Arkadeep Mitra
May 13, 2020·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Nancy Safwat Younis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.